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Regulation of Mast Cell Survival by IgE
promote proliferation and/or suppress apoptosis andKoichi Asai,1 Jiro Kitaura,1 Yuko Kawakami,1
Noboru Yamagata,2 Mindy Tsai,3 apoptosis driven by insufficient levels of growth factors
and other insults (reviewed in Galli et al., 1994; MekoriDavid P. Carbone,2 Fu-Tong Liu,1
Stephen J. Galli,3 and Toshiaki Kawakami1,4 et al., 1998; Galli and Lantz, 1999). To date, most work
on the regulation of mast cell survival and proliferation1Division of Allergy
La Jolla Institute for Allergy and Immunology has focused on the characterization of the effects of
various growth factors. These studies have established10355 Science Center Drive
San Diego, California 92121 that IL-3 represents an important mast cell growth and
survival factor in the mouse (Nabel et al., 1981; Nagao2 Division of Hematology and Oncology
Vanderbilt-Ingram Cancer Center et al., 1981; Razin et al., 1981; Schrader et al., 1981;
Tertian et al., 1981; Mekori et al., 1993; Iemura et al.,648 Preston Building (MRB II)
Nashville, Tennessee 37232 1994; Lantz et al., 1998) and that stem cell factor (SCF)
is a critical mast cell developmental and survival factor3 Department of Pathology
Department of Immunology in both mice and humans (reviewed in Galli et al., 1994;
Mekori et al., 1998; Galli and Lantz, 1999).Department of Microbiology
Stanford University School of Medicine In the present study, we show that exposure to mono-
meric IgE can render mast cells resistant to growth fac-3000 Pasteur Drive
Stanford, California 94305 tor depletion-induced apoptosis without inducing DNA
synthesis. While the survival-enhancing effect of IgE
requires an interaction between IgE and FcRI, FcRI
cross-linking is not involved. In fact, FcRI cross-linkingSummary
does not protect mast cells from apoptosis induced by
growth factor withdrawal. Remarkably, IgE-dependentMast cells play critical roles in hypersensitivity and in
defense against certain parasites. We provide evi- enhancement of survival does not appear to involve the
secretion of DNA synthesis-inducing growth factors ordence that mouse mast cell survival and growth are
promoted by monomeric IgE binding to its high-affinity to reflect changes in the expression of Bcl-2 family pro-
teins or interference with the FasL/Fas death pathway.receptor, FcRI. Monomeric IgE does not promote
DNA synthesis but suppresses the apoptosis induced
by growth factor deprivation. This antiapoptotic effect Results and Discussion
occurs in parallel with IgE-induced increases in FcRI
surface expression but requires the continuous pres- IgE Enhances Mast Cell Growth Induced by IL-3
ence of IgE. This process does not involve the FasL/ We first examined the effect of monomeric IgE on the in
Fas death pathway or several Bcl-2 family proteins vitro growth of bone marrow-derived mast cells (BMMC)
and induces a distinctly different signal than FcRI from strain 129 mice. BMMC were generated by main-
cross-linking. The ability of IgE to enhance mast cell taining femoral bone marrow cells for 4–5 weeks under
survival and FcRI expression may contribute to ampli- our standard conditions of culture, in which culture su-
fied allergic reactions. pernatants of mouse IL-3 gene-transfected cells (Yokota
et al., 1986) were used to provide approximately 0.5–5
Introduction ng/ml of IL-3 (Kawakami et al., 1992). The BMMC were
then washed and were newly plated in fresh medium
Mast cells are major effector cells in immunoglobulin (3 105 cells/1 ml aliquots) and cultured under the same
E (IgE)-dependent immediate hypersensitivity reactions conditions. The number of viable cells increased to
as well as in IgE-associated immune responses to cer- (6.5  0.45)  105 cells over a period of 8 days (Figure
tain parasites (Galli and Lantz, 1999). The exposure of 1A). Monoclonal IgE added to the cultures at the time
IgE-bound high-affinity IgE receptors (FcRI) on the of plating enhanced cell growth in a concentration-
mast cell surface to multivalent allergen results in cross- dependent manner. For instance, the addition of 10 g/
linking of the FcRI, which in turn leads to the activation ml of a monoclonal mouse anti-DNP IgE increased the
of the mast cells; this process culminates in the release number of viable cells to (9.7 1.40) 105 cells over the
of preformed inflammatory mediators, such as histamine same period. Essentially the same results were obtained
and proteases, and the de novo production and secre- when purified recombinant mouse IL-3 was used as a
tion of lipid mediators and cytokines. source of IL-3 (data not shown). IgE had similar effects
Mast cell numbers in vivo can change during the but of smaller magnitude, when tested with BMMC de-
course of IgE-associated immune responses, as well as rived from BALB/c or C57BL/6 mice (data not shown).
in many other settings (reviewed in Mekori et al., 1998; Growth potentiation was also exhibited by another
Galli and Lantz, 1999). Both in vitro and in vivo data monoclonal mouse IgE which is specific for dansyl (data
indicate that the sizes of tissue mast cell populations not shown), indicating that the growth-promoting ability
reflect a balance between the effects of factors that resides in the Fc portion of the IgE molecule. It is note-
worthy that 10 g/ml IgE is well within the concentration
range observed in the plasma of patients with parasite4 Correspondence: toshi_kawakami@liai.org
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1994; Yee et al., 1994). We next examined the effect of
IgE on cell death by performing flow cytometry on cells
stained with annexin V (to detect early apoptotic cells)
and propidium iodide (to detect dead cells). In the ab-
sence of these growth factors and IgE (even in the pres-
ence of fetal calf serum), BMMC from 129 mice died by
apoptosis in a time-dependent manner. Consistent with
a growth-promoting ability of IgE, such apoptotic cell
death was significantly attenuated by IgE (Figure 2A).
The extent of attenuation of apoptosis was dependent
on the IgE concentration (Figure 2B). For example, 96
hr after growth factor withdrawal, only 15%–20% of cells
treated with 10 g/ml IgE were annexin V-positive,
whereas as many as 55%–60% were annexin V-positive
without IgE (Figures 2A and 2C). Similar observations
were made with mouse mast cell lines MC/9 and MCP-5
(data not shown). Although we observed the antiapo-
ptotic effect of IgE on BMMC derived from other mouse
strains, a variability in the rate of cell death and IgE-
dependent survival effect was noticed among mouse
strains: the effects of IgE on mast cell survival were
higher on 129 BMMC than on BALB/c or C57BL/6 BMMC
(data not shown). When strain 129 mouse peritoneal
mast cells expanded in 3 week cultures in the presence
of SCF were incubated without SCF or IL-3, cell death
was again attenuated by IgE (data not shown). These
results indicate that the antiapoptotic effect of IgE is
not limited to a specific subtype of mast cells. Potential
contamination of IgE preparations with IL-3 or SCF was
unlikely because these cytokines were not used during
Figure 1. Monomeric IgE Promotes Mast Cell Growth without Induc- cultures of IgE hybridoma or purification of IgE (Ishizaka,
ing DNA Synthesis 1985). This possibility was further excluded by measur-
(A) Various concentrations of anti-DNP IgE were added to BMMC ing IL-3 (3 pg/ml) and SCF (20 pg/ml) in our IgE
cultures in the presence of culture supernatants of IL-3-transfected
preparations by ELISA. Moreover, these IgE prepara-cells for the indicated periods. Trypan blue-excluding cells were
tions did not enhance survival of mast cells that lackedcounted by a hemocytometer. Asterisks indicate statistically signifi-
the  chain of FcRI and therefore could not bind IgEcant differences (p  0.05) in cell numbers between cells treated
with 10 g/ml versus no IgE. to FcRI (see below). Notably, we found the IgE-induced
(B) BMMC were incubated with various concentrations of mono- FcRI upregulation even in the absence of IL-3 and SCF
meric IgE for 24 hr in the presence or absence of IL-3 or SCF. Cells (data not shown).
were incubated with [3H]thymidine during the last 6 hr. The acid-
insoluble fraction of radioactivity was measured by a scintillation
IgE Exerts Its Effect on Survival by Binding to FcRIcounter.
Mouse mast cells express a limited variety of IgE binding
surface receptors: FcRI, FcRII, FcRIIIA, and galec-
tin-3 (Kinet, 1999). The low-affinity IgE receptor FcRIIinfection and at the extreme range of that found in atopic
patients (Knauer and Adkinson, 1983). Serum IgE levels (or CD23) is not expressed in BMMC. Although FcRII/
III can bind IgE immune complexes (Takizawa et al.,of NC/Nga mice, a recently described model for allergic
dermatitis, can reach 80 g/ml or higher (Matsuda et 1992), IgE can induce both upregulation of FcRI and
mast cell survival, while IgG that binds to FcRII/III hasal., 1997).
We next investigated whether the IgE-dependent neither effect (Figure 2C and Yamaguchi et al., 1997).
BMMC were generated from FcRI (F.-T.L., unpub-growth promotion reflected an ability of IgE to enhance
DNA synthesis. However, in the absence of IL-3, up to lished data) or galectin-3 (Hsu et al., 2000) null mutant
mice. As expected, FcRI/ mast cells did not express100 g/ml monomeric IgE did not induce significant
levels of [3H]thymidine uptake into the DNA of BMMC surface FcRI before or after IgE treatment; moreover,
these cells were unresponsive to the survival-promoting(Figure 1B). Addition of IgE to the cultures maintained
with IL-3 or SCF did not increase thymidine uptake any effects of IgE (Figure 3). By contrast, galectin-3/ mast
cells behaved just like wild-type mast cells in that IgEfurther (Figure 1B). Therefore, monomeric IgE appears
to enhance mast cell growth through an effect other treatment induced both upregulation of FcRI expres-
sion and enhanced survival upon growth factor deple-than the direct stimulation of DNA synthesis.
tion (data not shown). In addition, wild-type BMMC that
were incubated with 10 g/ml IgE in the presence ofIgE Protects Mast Cells from Growth Factor
Depletion-Induced Apoptosis 25 mM -lactose, which prevents IgE from binding to
galectins, exhibited both increased cell survival andMast cells, including BMMC, die by apoptosis when
growth factors such as IL-3 and SCF are removed from FcRI expression (data not shown). Taken together,
these findings indicate that most, if not all, of the abilitythe culture medium (Mekori et al., 1993; Iemura et al.,
Mast Cell Survival by IgE
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Figure 2. Monomeric IgE Antagonizes Mast
Cell Apoptosis Induced by Growth Factor
Deprivation
(A and B) BMMC were incubated with 0–10
g/ml (0 or 10 g/ml [A]) monomeric anti-
DNP IgE in the absence of IL-3 (with 10%
FCS) for 96 hr (B) or the indicated periods
(A). In (A), another set of cells was sensitized
overnight with 0.5 g/ml anti-DNP IgE and
stimulated with 30 ng/ml DNP21-HSA for the
indicated periods. Cells were stained with
FITC-annexin V and propidium iodide. Per-
centages of annexin V/propidium iodide
cells were plotted.
(C) BMMC were incubated for 96 hr with or
without 10 g/ml monomeric anti-DNP IgE in
the absence of IL-3 (with 10% FCS). Controls
include cells incubated with IL-3 but without
IgE and cells without IL-3 but with 10 g/
ml IgG. Another set of cells was sensitized
overnight with 0.5 g/ml anti-DNP IgE and
then stimulated with 30 ng/ml DNP21-HSA for
96 hr. Cells were stained with FITC-annexin
V and propidium iodide followed by flow cyto-
metric analysis. Percentages of annexin V/
propidium iodide cells are shown.
of IgE to render mast cells resistant to growth factor The Antiapoptotic Effect of IgE Requires
the Continuous Presence of the Antibodydepletion-induced apoptosis (this study), as well as to
upregulate FcRI expression (MacGlashan et al., 1999), When we examined the effect of higher IgE concentra-
tions on the survival and surface FcRI levels of BMMC,reflects the binding of IgE to FcRI.
Figure 3. Effect of Monomeric IgE on Sur-
vival of Growth Factor-Depleted FcRI/
BMMC
Wild-type and FcRI/ BMMC were incu-
bated with or without 10 g/ml monomeric
anti-DNP IgE in the presence or absence of
IL-3 for 4 days. Cells were first blocked with
2.4G2 mAb and saturated with IgE and then
stained with FITC-anti-mouse IgE and PE-
anti-Kit followed by flow cytometry (left pan-
els). Another set of cells was stained with
FITC-annexin V and propidium iodide before
flow cytometry (right panel; * 	 p  0.05 ver-
sus results for each other group).
Immunity
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Figure 4. Effect of FcRI Levels on Survival of Growth Factor-Depleted BMMC
BMMC were incubated with 0–5 g/ml monomeric IgE in the presence of IL-3 for 2 days, and the cells were then incubated without IL-3 in
the presence or absence of 10 g/ml IgE for the next 3 days. Surface expression of FcRI on day 2 and day 5 (cultured with or without IgE
for the last 3 days) (left) and survival on day 5 (annexin V/propidium iodide cells; right) were measured by flow cytometry. * 	 p  0.05
versus results for cells maintained in IL-3 (without IgE) for the entire 5 day period.
we observed increased survival and FcRI levels in par- 3 days (data not shown). These data indicate (1) that
FcRI levels per se do not seem to influence mast cellallel at least up to 100 g/ml IgE (data not shown). These
results therefore differ somewhat from those in a previ- survival under the conditions tested, and (2) that the
continuous presence of IgE is required for the antiapo-ous study (Figure 1C in Yamaguchi et al., 1997) in which
surface expression of FcRI exhibited a level off at a ptotic effect.
concentration of 50 g/ml IgE. However, whether one
analyzes the effect of monomeric IgE on upregulation FcRI Cross-Linking Does Not Induce Resistance
to Growth Factor Depletion-Induced Apoptosisof the FcRI or on survival, the effects continue to in-
crease at unexpectedly high concentrations of IgE. In contrast with the effect of monomeric IgE on BMMC
survival, FcRI cross-linking did not promote the survivalGiven these parallel IgE effects on FcRI upregulation
and enhanced cell survival, we evaluated whether in- of BMMC after growth factor withdrawal. Cells that had
been sensitized overnight with 0.5 g/ml IgE and thencreased FcRI expression alone is sufficient for the anti-
apoptotic effect. BMMC were incubated with 0–5 g/ml were stimulated with 0.01–100 ng/ml antigen with a high
valency (DNP21-HSA) exhibited levels of annexin V posi-monomeric IgE in the presence of IL-3 for 2 days (to
result in various levels of enhancement of FcRI surface tivity that were similar to those that were incubated
without IgE (Figure 2C and data not shown). Moreover,expression), and the cultures were continued without
IL-3 in the presence or absence of 10 g/ml IgE (to because we were concerned about the potential con-
tamination of our IgE preparations with IgE oligomers,provide a strong IgE-dependent effect) for the next 3
days. As shown in Figure 4, surface expression of FcRI we also examined the effect of FcRI cross-linking with
low-valency antigen. We found that various concentra-was increased in an IgE concentration-dependent man-
ner in cells assessed either on day 2 or on day 5 [labeled tions (0.01–100 ng/ml) of DNP3-HSA also failed to render
growth factor-deprived cells resistant to apoptosis (data“Day 5 (IgE after Day 2)” in Figure 4A], even though
IgE had been withdrawn from the medium for the last 3 not shown). Next, to avoid the confounding effect of
oligomer contamination as much as possible, we furtherdays in the latter set of cells. The FcRI levels on day 5
in the presence of 10 g/ml IgE [labeled “Day 5 (
IgE purified monomeric IgE from our conventional IgE prep-
arations by ultracentrifugation and gel filtration, per-after Day 2)” in Figure 4A] were much higher than those
on day 2 at all IgE concentrations. Notably, very similar formed just before the incubations of BMMC with IgE.
Using these preparations, we observed growth-promot-levels of apoptosis were observed in mast cells that
entered the period of growth factor and IgE withdrawal ing and antiapoptotic effects (data not shown) that were
similar to those of our conventional IgE preparationswith low or high levels of FcRI surface expression (Fig-
ure 4B). In contrast, the cells treated with 10 g/ml IgE (which were purified by ammonium sulfate fractionation
followed by DEAE column chromatography). Gel filtra-during the last 3 days exhibited similarly higher survival
rates, irrespective of FcRI levels at the beginning of tion indicates that our conventional IgE preparations
typically contain 20% contamination of dimeric and/IL-3 deletion (Figure 4B). Similar results were observed
when the same experiment was performed, except that or oligomeric IgE (data not shown). Therefore, the results
with our conventional IgE preparations suggest that5 g/ml instead of 10 g/ml IgE was used for the last
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crine secretion of significant amounts of mast cell
growth factors but are consistent with the possibility that
the binding of monomeric IgE to FcRI instead induces
intracellular changes in the mast cells.
IgE Treatment of Mast Cells Induces Intracellular
Responses that Differ from Those Induced
by FcRI Cross-Linking
Given the differential effects of IgE treatment versus
FcRI cross-linking on apoptosis and FcRI expression,
we compared the expression of intracellular signaling
events in mast cells that were incubated with monomeric
IgE or activated by cross-linking of FcRI. None of the
early activation events associated with FcRI cross-link-
ing (reviewed in Turner and Kinet, 1999), such as tyrosine
phosphorylation in general or activation or phosphoryla-
tion of Akt or MAP kinases (i.e., ERK1/2, JNK1, and p38),
Figure 5. IgE-Conditioned Culture Media Do Not Contain Mast Cell were reproducibly detected in BMMC treated with 10
Growth Factors
g/ml IgE for 3, 6, 9, or 24 hr (Figure 6A). Consistent
Culture supernatants were recovered from BMMC which had been with these data, we found that IgE-treated BMMC de-
incubated with 10 g/ml anti-DNP IgE in the absence of IL-3 for 1,
rived from lyn/ or btk/ mice exhibited enhanced resis-3, or 4 days. Fresh BMMC were incubated with these supernatants
tance to growth factor (IL-3) depletion-induced apopto-for 24 hr. [3H]thymidine was present in the cultures during the last
6 hr. The acid-insoluble fraction of radioactivity was measured by sis and that BMMC derived from lyn/ or btk/ mice
a scintillation counter. Only data with supernatants from 3 day cul- exhibited a remarkable (over 10-fold) enhancement in
tures are shown. The other cultures gave similarly negative results. FcRI expression just like wild-type BMMC after 2 days
IL-3 and SCF were tested as positive controls. of incubation with 0.5–5 g/ml IgE (data not shown).
These results indicate that neither of these PTKs are
essential for the expression of IgE-dependent effects
antiapoptotic effects induced by monomeric IgE are in- on mast cell survival or FcRI upregulation. In addition,
dependent of or dominant over whatever signals might we found that double mutant mast cells from btk//
be generated by low-level FcRI cross-linking by the IgE lyn/ mice, which were previously shown to exhibit a
dimers or oligomers in these preparations. These results severely impaired ability to degranulate and to produce
also indicate that, under the conditions tested, neither cytokines (Kawakami et al., 2000), responded to IgE like
high-level nor low-level cross-linking of FcRI induces wild-type mast cells, with an increased resistance to
resistance to apoptosis induced by growth factor growth factor depletion-induced apoptosis and en-
depletion. hanced FcRI expression (data not shown). Therefore,
the ability of IgE to enhance FcRI expression and to
promote survival either does not require PTKs at all orThe IgE-Dependent Survival Effect Does Not Seem
to Involve an Autocrine Mechanism of Growth the residual PTK activity in mutant mast cells that lack
Btk and Lyn is sufficient for these phenomena to occur.Factor Secretion
Mast cells produce some cytokines constitutively and We also examined whether certain late events in-
duced by FcRI cross-linking can be induced by mono-secrete these and de novo synthesized cytokines in
response to FcRI stimulation (Galli and Lantz, 1999). meric IgE. Transcriptional activation of reporter con-
structs such as TNF-/luc (Figure 6B) and IL-2/luc (dataTherefore, we investigated the possibility that mono-
meric IgE binding to FcRI triggers secretion of a cyto- not shown) was robustly induced in FcRI-stimulated
but not in monomeric IgE-treated cells. The transcrip-kine(s) that has a mast cell growth-promoting ability. To
this end, we tested whether culture media, in which tional activity of FcRI/luc and FcRI/luc constructs
driven by the promoter of the rat FcRI  and  subunitBMMC were incubated with 10 g/ml anti-DNP IgE in
the absence of IL-3 for 1, 3, or 4 days, contained such genes, respectively, was slightly increased by FcRI
cross-linking but not at all by monomeric IgE (Figurean activity. Fresh BMMC cultured in these conditioned
media for 24 hr did not incorporate significant levels of 6B). The transcriptional activity in BMMC was also com-
pared by DNA microarray analysis among six different[3H]thymidine into the DNA (Figure 5). Consistent with
these results, these conditioned media did not contain culture conditions: (1) with IL-3 (10% conditioned me-
dium of the IL-3-transfected cells [Yokota et al., 1986])detectable levels of mast cell growth factors such as
SCF (1 ng/ml in thymidine uptake assays), IL-3 (10 in the absence of IgE for 24 hr; (2) with IL-3 in the pres-
ence of 10 g/ml IgE for 24 hr; (3) without IL-3 in thepg/ml in thymidine uptake assays), IL-4 (9.77 pg/ml in
ELISA), IL-5 (97.7 pg/ml in ELISA), IL-6 (15.6 pg/ml absence of IgE for 6 hr; (4) without IL-3 in the presence
of IgE for 6 hr; (5) without IL-3 in the absence of IgE forin ELISA), IL-9 (30 pg/ml in ELISA), IL-13 (97.7 pg/
ml in ELISA), or INF- (39.1 pg/ml in ELISA) or other 24 hr; and (6) without IL-3 in the presence IgE for 24 hr.
Expression of very few (0.4%) genes among 11,000cytokines that can be secreted from FcRI-stimulated
mast cells such as IL-2 (3.1 pg/ml in ELISA) and TNF- genes contained in the gene filters (Rat GeneFilters Re-
lease I and II from Research Genetics) used was signifi-(15.4 pg/ml in ELISA). These data suggest that the IgE-
dependent antiapoptotic effect does not involve auto- cantly (i.e., more than 2-fold up or down) affected by
Immunity
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Figure 6. Differential Signaling Events Induced by Monomeric IgE and FcRI Cross-Linking
(A) BMMC were incubated without IL-3 in the presence or absence of 10 g/ml anti-DNP IgE. Another group of cells was sensitized overnight
with 0.5 g/ml anti-DNP IgE and stimulated with 100 ng/ml DNP21-HSA for the indicated periods. Cell lysates were analyzed by immunoblotting
with phospho-specific antibodies that recognize activated ERK1 and ERK2, p38, or Akt. Some lysates were immunoprecipitated with anti-
JNK1 antibody, and the immune complexes were subjected to in vitro kinase assays using GST-c-Jun as a substrate. The same blots were
reprobed with respective antibodies that recognize these MAPKs, irrespective of the phosphorylation state.
(B) BMMC were transfected with 10g TNF- (-200)/luc, FcRI/luc, or FcRI/luc plasmid by electroporation. Transfected cells were incubated
with or without 10 g/ml anti-DNP IgE for 24 hr before cell harvest for luciferase assays. Some cells were sensitized overnight with 0.5 g/
ml anti-DNP IgE and stimulated with 1 or 10 ng/ml DNP21-HSA for the last 8 hr. * 	 p  0.05 versus corresponding values for cells treated
with medium alone.
(C) BMMC were incubated with or without IL-3 in the presence or absence of anti-DNP IgE for 6 or 24 hr. Global gene expression was analyzed
by DNA microarray (see text). Expression levels in arbitrary units of 1200 known genes in pairwise comparisons are plotted. Each dot represents
a gene. Two lines (y 	 0.5x and y 	 2x) are drawn in each plot, as a guide for significant difference. Out of 11,064 genes and ESTs tested,
expression of 3, 36, and 3 genes each was upregulated by IgE more than 2-fold in the three comparisons shown in the graphs (from left to
right), while expression of 0, 3, and 11 genes was downregulated more than 2-fold in the respective comparisons.
these conditions, either when conditions 2 through 6 signals that are distinctly different from those induced
by FcRI cross-linking.were compared with the continuous IL-3-dependent cul-
ture condition (1) or when all of the conditions were
compared pairwise to all other conditions. Figure 6C The IgE-Dependent Antiapoptotic Effect Is
Independent of Both the FasL/Fas Deathshows an example of such an analysis. Another analysis
was performed using a custom-made DNA microarray Pathway and Several Bcl-2 Family Proteins
The FasL/Fas death pathway is important in regulatingof 5000 mouse genes. Among the 4294 genes which
yielded significant signals, no genes exhibited signifi- the survival of cytotoxic T cells, and this system plays
a critical role in the peripheral clonal deletion of autore-cant differences in expression between all the combina-
tions of four culture conditions: (1) with IL-3 (10% condi- active T cells and the downregulation of activated T
cells (Nagata and Golstein, 1995; Green and Ware, 1997).tioned medium of the IL-3-transfected cells [Yokota et
al., 1986]) without IgE for 3 hr; (2) with IL-3 plus 10 g/ Fas is also expressed in IL-3-derived BMMC (Hartmann
et al., 1997). Accordingly, we examined the possibleml IgE for 3 hr; (3) without IL-3 or IgE for 3 hr; and (4)
without IL-3, with 10 g/ml IgE for 3 hr (data not shown). involvement of the FasL/Fas system in IgE-dependent
resistance to growth factor depletion-induced apopto-No component of FcRI was transcriptionally up- or
downregulated under the tested conditions (data not sis. To this end, we examined BMMC derived from FasL-
deficient gld and Fas-deficient lpr mice. We found thatshown). It was recently shown that expression of numer-
ous genes are changed upon FcRI cross-linking (Chen these cells expressed FcRI at levels similar to those
on normal controls, and both lpr and gld mast cellset al., 1998). Taken together, these results strongly sug-
gest that the binding of monomeric IgE to FcRI induces exhibited IgE-dependent resistance to growth factor de-
Mast Cell Survival by IgE
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Figure 7. IgE-Dependent Promotion of Mast
Cell Survival Does Not Involve the FasL/Fas
Death Pathway, and IgE Treatment Does Not
Induce Changes in the Expression of Several
Bcl-2 Family Proteins
(A) BMMC from wild-type, gld, and lpr mice
were incubated without IL-3 in the presence
or absence of various concentrations of anti-
DNP IgE for 24 hr. Cells were analyzed as
shown in Figure 2B. * 	 p  0.05 versus re-
sults with cells of the same genotype treated
with no IL-3 or IgE; †	 p 0.05 versus results
for wild-type cells treated with the same con-
centration of IgE.
(B) Expression of Bcl-2 family proteins was
analyzed by immunoblotting as described in
Experimental Procedures.
pletion-induced apoptosis (Figure 7A). However, these IgE binding  chain of FcRI. And while the survival-
promoting effect occurs in parallel with the previouslycells tended to exhibit lower cell survival rates than wild-
type mast cells under either IL-3-rich or growth factor- described ability of IgE to enhance surface expression
of FcRI (Hsu and MacGlashan, 1996; Yamaguchi et al.,deprived conditions. The reason for the relatively poor
survival of gld and lpr BMMC is not known. 1997, 1999; Lantz et al., 1997; Yano et al., 1997; Xia et
al., 1997; MacGlashan et al., 1998), the antiapoptoticBecause Bcl-2 family proteins are pro- or antiapo-
ptotic under numerous conditions (Green and Reed, effect of IgE requires continued exposure to the IgE,
whereas the IgE-induced enhancement of FcRI surface1998), we also examined the potential involvement of
several Bcl-2 family proteins in the IgE-dependent anti- expression persists for a few days after the withdrawal
of IgE (Figure 4).apoptotic effect. Expression of the antiapoptotic mem-
bers Bcl-2 and Bcl-XL and the pro-apoptotic members Remarkably, the ability of IgE to enhance mast cell
Bad, Bak, Bax, and Mcl-1 was analyzed by immunoblot- survival appears to occur without detectable changes
ting of lysates of BMMC that had been incubated with in the expression of many members of the Bcl-2 family
or without 10 g/ml IgE in the presence or absence of of proteins, including some, such as Bcl-XL and BAD,
IL-3. We found that none of these proteins was signifi- that have previously been implicated in the signaling by
cantly increased or decreased by incubation of the cells which IL-3 or SCF can promote mast cell survival (Yang
with monomeric IgE (Figure 7B), suggesting that these et al., 2000). Nor have we been able to generate any
Bcl-2 proteins are not critical targets of the IgE survival evidence that the interaction of mast cells with mono-
effect. meric IgE can induce the detectable release of cytokines
that might have autocrine effects on mast cell survival
or proliferation. Indeed, using a variety of approaches,Conclusions
we have detected little, if any, changes in the intracellu-We have demonstrated that monomeric IgE can promote
lar signaling pathways that are known to be effected bymast cell growth by suppressing apoptosis under
the cross-linking of FcRI. These results are in accordgrowth factor-limiting conditions. This effect clearly is
with the widely held view that the interaction of IgEmediated by the binding of IgE to FcRI, since the effect
is not observed in mast cells that genetically lack the with FcRI per se does not induce intracellular signaling
Immunity
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Faslpr, and B6Smn.C3H-Faslgld mice were cultured in IL-3-containing(Beaven and Metzger, 1993; Turner and Kinet, 1999).
medium for 4–6 weeks to generate 95% pure populations of mastOur gene microarray studies indicate that exposure of
cells (BMMC). Cells were incubated with various concentrations ofmast cells to IgE may induce the enhanced expression
anti-DNP IgE monoclonal antibody for the indicated periods. For
of a very small subset of the genes analyzed (40 genes FcRI cross-linking, cells incubated overnight with 0.5 g/ml anti-
of approximately 11,000 tested). However, exposure of DNP IgE were stimulated with antigen, 0.1–100 ng/ml DNP21-HSA
(a gift from Dr. Teruko Ishizaka, La Jolla Institute for Allergy andmast cells to monomeric IgE induces enhanced FcRI
Immunology) for regular high-level cross-linking or 0.1–100 ng/mlsurface expression (Hsu and MacGlashan, 1996; Yama-
DNP3-HSA (Biosearch Technologies, Inc.) for low-level cross-linking.guchi et al., 1997, 1999; Lantz et al., 1997; Yano et al.,
Peritoneal mast cells were expanded in cultures containing re-1997; Xia et al., 1997; MacGlashan et al., 1998), as well
combinant rat SCF (Amgen). In brief, the peritoneum of 129/Sv mice
as enhanced survival under growth factor-limiting condi- was exposed by 1–2 cm midline abdominal incision, and 5 ml of
tions (this study). The extent to which the changes in 0.9% NaCl and 5 ml of air were injected into the peritoneal cavity.
The abdomen was massaged gently, and the peritoneal fluid wasgene expression associated with exposure of mast cells
recovered in a syringe via a 22 gauge needle. Peritoneal cells wereto IgE is involved in either enhancement of FcRI surface
recovered by a brief centrifugation, resuspended in, and culturedexpression or the promotion of mast cell survival re-
in, RMPI1640 medium containing recombinant SCF for 3 weeksmains to be determined.
before use. Expression of FcRI and c-Kit during the cultures were
The discovery that IgE is the “reagin” that can confer monitored by flow cytometry as described below. At the end of
antigen specificity to allergic disorders and result in the culture, the cells were collected by cytospin and stained with May-
Giemsa solution.long-term sensitization of tissue mast cells was a major
advance in our understanding of the pathophysiology
Flow Cytometryof allergic diseases (Ishizaka et al., 1966), as was the
For the measurement of FcRI and c-Kit, BMMC were incubateddiscovery of the FcRI (Kulczycki and Metzger, 1974).
first with 10 g/ml 2.4G2 mAb (BD PharMingen) at 4C for 10 min,It now appears that the interaction of IgE with FcRI has
then with 5g/ml anti-DNP IgE for 50 min, and then FITC-conjugated
two effects in addition to that of priming mast cells anti-mouse IgE (BD PharMingen) and PE-conjugated anti-c-Kit mAb
to undergo degranulation and mediator production in (BD PharMingen) for another 30 min. In order to monitor apoptosis,
cells were incubated with 1 g/ml FITC-labeled annexin V (Clontech)response to the aggregation of the receptors that is
and 2.5 g/ml propidium iodide (Clontech) at room temperature forinduced by the binding of IgE to di- or multivalent anti-
15 min in the dark. Flow cytometric analysis of the stained cellsgens. IgE can markedly enhance surface expression of
was performed with FACScan or FACSCalibur (Becton-Dickinson)FcRI, and this in turn can significantly enhance the
equipped with CellQuest software.
effector function of the cells, both by permitting them
to undergo degranulation at lower concentrations of an- Cytokines
tigen and by permitting them to release larger amounts Supernatants of BMMC that had been incubated with 10 g/ml anti-
DNP IgE in the absence of IL-3 were measured in ELISA for theof preformed mediators, lipid products, and cytokines
following cytokines: IL-2, IL-4, IL-5, IL-9, IL-13, TNF-, and INF-in response to IgE-dependent activation (Hsu and Mac-
(BD PharMingen or Endogen).Glashan, 1996; Yamaguchi et al., 1997, 1999; Yano et
al., 1997). Our present study indicates that IgE can also
Immunoblotting Analysis and Antibodies
promote the survival of mast cells under conditions of Mast cells were lysed in 1% NP-40-containing lysis buffer (20 mM
growth factor limitation. This finding suggests yet an- Tris-HCl [pH 8.0], 0.15 M NaCl, 1 mM EDTA, 1 mM sodium orthovana-
other mechanism by which the elevated levels of IgE date, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, 10
g/ml leupeptin, 25 M p-nitrophenyl p-guanidinobenzoate, 1 Massociated with allergic disorders and host immunity to
pepstatin, and 0.1% sodium azide). Cell lysates were analyzedparasites might promote the expression of these re-
by SDS-PAGE followed by immunoblotting. Antibodies used forsponses. The elucidation of the mechanism by which
probing were anti-phospho-p44/42 MAP kinase (Thr202/Tyr204),
exposure to monomeric IgE can enhance mast cell sur- anti-phospho-p38 MAP kinase (Thr180/Tyr182), anti-phospho-Akt
vival will be of substantial interest. However, given the (Ser473), and respective antibodies that recognize these MAP ki-
results presented herein, the characterization of this nases or Akt irrespective of their phosphorylation states (from Cell
Signaling Technology, Inc.). Antibodies that recognize Bcl-2 (SC-mechanism may represent a significant challenge.
492), Bcl-XS/L (SC-634), Bax (SC-526), BAD (SC-942), Bak (SC-832),
and Mcl-1 (SC-958) were from Santa Cruz Biotechnology. Anti-phos-Experimental Procedures
photyrosine mAb 4G10 was purchased from Upstate Biotechnology.
Proteins reactive with primary antibody were visualized with an HRP-IgE Preparations
conjugated secondary antibody and enhanced chemiluminescenceAnti-DNP mouse IgE monoclonal antibody (Liu et al., 1980) was
reagents (NEN Life Science Products).purified as described previously. In brief, ascites recovered from
CAF1/J mice harboring the IgE hybridoma were first fractionated
Kinase Assaysby ammonium sulfate. IgE-containing fractions were further purified
For JNK assays, anti-JNK1 (SC-474) immunoprecipitates were incu-by DEAE column chromatography. Protein concentrations were
bated with 3 g GST-c-Jun(1-79) in 15 min reactions at 30C in 20measured by spectrophotometry and confirmed by SDS-PAGE anal-
mM HEPES (pH 7.4), 10 mM MgCl2, 22 mM DTT, 20 mMysis followed by staining with Coomassie brilliant blue (our conven-
-glycerophosphate, 50 M Na3VO4, 20 M ATP, and 10 Citional IgE preparations). In order to obtain monomeric IgE, these
[-32P]ATP. Reactions were analyzed by SDS-PAGE, blotting, andpreparations were ultracentrifuged and supernatants further purified
autoradiography.by Sepharose gel filtration column chromatography. Anti-dansyl
mouse IgE mAb was purchased from BD PharMingen and ultracen-
trifuged before use. Transcription Assays
Luciferase reporter constructs, the mouse IL-2 (-321)/luc, and the
human TNF- (-200)/luc were described previously (Hata et al.,Cell Culture and Stimulation
Femoral bone marrow cells derived from wild-type (129/Sv, BALB/c, 1998). Mast cells (1–1.5  107) were transfected with 5–10 g re-
porter plasmid by electroporation at 400V, 950 F, using a Geneand C57BL/6), btk knockout (Khan et al., 1995), lyn knockout (Chan et
al., 1997), btk/lyn double knockout (Kawakami et al., 2000), B6.MRL- Pulser II apparatus (Bio-Rad). Transfected cells were incubated with
Mast Cell Survival by IgE
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or without 10 g/ml anti-DNP IgE for 24 hr before cell harvest. Cells Ishizaka, K. (1985). Immunoglobulin E (IgE). Methods Enzymol. 116,
76–94.were lysed in 0.2% Triton X-100 in 100 mM potassium phosphate
buffer (pH 7.8)/1 mM DTT. Luminescence of cleared lysates was Ishizaka, K., Ishizaka, T., and Hombrook, M.M. (1966). Physico-
measured after addition of luciferin solution using a model Monolight chemical properties of human reaginic antibody IV. Presence of a
2010 luminometer (Analytical Luminescence Laboratory). unique immunoglobulin as a carrier of reaginic activity. J. Immunol.
Analysis of the global transcriptional activity was performed using 97, 75–85.
two different DNA microarrays. Total cellular RNA was extracted
Kawakami, T., Inagaki, N., Takei, M., Fukamachi, H., Coggeshall,
using a TRIZOL reagent (Life Technologies, Inc.) from BMMC cul-
K.M., Ishizaka, K., and Ishizaka, T. (1992). Tyrosine phosphorylation
tured with or without 10 g/ml anti-DNP IgE for 3, 6, or 24 hr.
is required for mast cell activation by FcRI cross-linking. J. Immu-
For the analysis with Rat GeneFilters Release I and II (Research
nol. 148, 3513–3519.
Genetics), cDNA preparation and labeling with [-33P]ATP, hybridiza-
Kawakami, Y., Kitaura, J., Satterthwaite, A.B., Kato, R.M., Asai, K.,tion, and expression analysis were performed at the Genomics Core
Hartman, S.E., Maeda-Yamamoto, M., Lowell, C.A., Rawlings, D.J.,Laboratory, Center for AIDS Research, University of California San
Witte, O.N., and Kawakami, T. (2000). Redundant and opposingDiego. For the analysis with a custom-made mouse cDNA microar-
functions of two tyrosine kinases, Btk and Lyn, in mast cell activa-ray, T7 RNA ploymerase-based antisense RNA amplification and
tion. J. Immunol. 165, 1210–1219.labeling with Cy3 and Cy5 (Luo et al., 1999; Wang et al., 2000),
Khan, W.N., Alt, F.W., Gerstein, R.M., Malynn, B.A., Larsson, I., Rath-hybridization, and expression analysis by GenePix 4000A scanner
bun, G., Davidson, L., Mueller, S., Kantor, A.B., Herzenberg, L.A., etand GenePix Pro software (both from Axon Instruments, Inc.) were
al. (1995). Defective B cell development and function in Btk-deficientperformed by N.Y. and D.P.C.
mice. Immunity 3, 283–299.
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